177 related articles for article (PubMed ID: 31003735)
1. Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients.
Allard M; Puszkiel A; Conti F; Chevillard L; Kamar N; Noé G; White-Koning M; Thomas-Schoemann A; Simon T; Vidal M; Calmus Y; Blanchet B
Clin Ther; 2019 May; 41(5):882-896.e3. PubMed ID: 31003735
[TBL] [Abstract][Full Text] [Related]
2. Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
Fontova P; Colom H; Rigo-Bonnin R; Bestard O; Vidal-Alabró A; van Merendonk LN; Cerezo G; Polo C; Montero N; Melilli E; Manonelles A; Meneghini M; Coloma A; Cruzado JM; Torras J; Grinyó JM; Lloberas N
Clin Pharmacol Ther; 2021 Jul; 110(1):238-247. PubMed ID: 33626199
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
[TBL] [Abstract][Full Text] [Related]
4. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant.
DuBay DA; Teperman L; Ueda K; Silverman A; Chapman W; Alsina AE; Tyler C; Stevens DR
Clin Pharmacol Drug Dev; 2019 Nov; 8(8):995-1008. PubMed ID: 30667591
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
7. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
Blanchet B; Duvoux C; Costentin CE; Barrault C; Ghaleh B; Salvat A; Jouault H; Astier A; Tod M; Hulin A
Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
[TBL] [Abstract][Full Text] [Related]
9. A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study.
Dumortier J; Duvoux C; Dubel L; Bazin F; Houssel-Debry P
Ann Transplant; 2019 Aug; 24():506-516. PubMed ID: 31451681
[TBL] [Abstract][Full Text] [Related]
10. A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers.
Zaltzman JS; Lai V; Schulz MZ; Moon KH; Cherney DZ
Transpl Int; 2014 Dec; 27(12):1294-302. PubMed ID: 25160518
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation.
Méndez A; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Blanco A; Camós S; Pou L; Roman A
Transplantation; 2014 Feb; 97(3):358-62. PubMed ID: 24492423
[TBL] [Abstract][Full Text] [Related]
12. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy.
Ericzon BG; Varo E; Trunečka P; Fischer L; Colledan M; Gridelli B; Valdivieso A; O'Grady J; Dickinson J; Undre N
Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28295581
[TBL] [Abstract][Full Text] [Related]
14. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
[TBL] [Abstract][Full Text] [Related]
15. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
[TBL] [Abstract][Full Text] [Related]
16. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
[TBL] [Abstract][Full Text] [Related]
18. Once-daily, prolonged-release tacrolimus vs twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: A Phase 4, randomized, open-label, comparative, single-center study.
Shin MH; Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Yun YI; Kim WJ; Kang WH; Kim SH; Jiang H; Lee S; Tak EY
Clin Transplant; 2018 Sep; 32(9):e13376. PubMed ID: 30098071
[TBL] [Abstract][Full Text] [Related]
19. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
Kolonko A; Chudek J; Wiecek A
Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
[TBL] [Abstract][Full Text] [Related]
20. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
